Proteus Digital Health Stock

proteus.comHealthcareFounded: 2004Funding to Date: $397.36MM

Proteus Digital Health is a biotechnology company focused on creating a new category of pharmaceuticals: Digital Medicines, which include drugs that communicate when they’ve been taken, wearable sensors that capture physiologic response, applications that support patient self-care and physician decision making, and data analytics to serve the needs of doctors and health systems.

Register for Details

For more details on financing and valuation for Proteus Digital Health, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Proteus Digital Health.

Register Today

Proteus Digital Health investors also invested in these private companies


Management Team

Andrew Thompson
George Savage, M.D.
Co-Founder, Chief Medical Officer
Mark Zdeblick, Ph.D.

Board Members

Shumeet Banerji, Ph.D.
Frank Fischer
Immanuel Thangaraj
Regina Benjamin, MD, MBA
Alan J. Levy, Ph.D.
Joseph R. Swedish
Andrew Thompson
Sir Jonathan Symonds, CBE
Robert Epstein, M.D., M.S.
Ryan Schwarz

Other companies like Proteus Digital Health in the Healthcare sector

Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation


3D-printed and “smart” pharmaceuticals are making medical treatments more effective. But it may take years before the new devices reach most patients, if they do at all.
NEW YORK, Feb. 6, 2019 /PRNewswire/ -- INTRODUCTION Poor adherence to prescribed medications is a growing concern in the healthcare industry and is believed to ...
スタッキング可能 スツール M-22